MarketCap
Facebook
X
TelegramQuarterly report 2025-Q3
added 11-05-2025
Zimmer Biomet Holdings Total Liabilities 2011-2026 | ZBH
Annual Total Liabilities Zimmer Biomet Holdings
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 8.89 B | 9.01 B | 9.04 B | 10.8 B | 12.2 M | 12.2 B | 12.9 B | 14.2 B | 17 B | 17.3 B | 3.11 B | 3.28 B | 3.15 B | 3 B |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 17.3 B | 12.2 M | 8.85 B |
Quarterly Total Liabilities Zimmer Biomet Holdings
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 10.7 B | 10.3 B | 9.78 B | 9.34 B | 8.77 B | 8.85 B | 8.7 B | 8.92 B | 9.09 B | 9.04 B | 9.08 B | - | 9.6 B | 10.8 B | 11.3 B | 11.6 B | 10.8 B | 12.2 B | 12.2 B | 12.2 B | 12.2 B | 12.2 B | 12.2 B | 12.2 B | 12.2 B | 12.9 B | 12.9 B | 12.9 B | 12.9 B | 14.3 B | 14.3 B | 14.3 B | 14.3 B | 17 B | 17 B | 17 B | 17 B | 17.3 B | 17.3 B | 17.3 B | 17.3 B | 3.11 B | 3.11 B | 3.11 B | 3.11 B | 3.28 B | 3.28 B | 3.28 B | 3.28 B | 3.15 B | 3.15 B | 3.15 B | 3.15 B | 3 B | 3 B | 3 B | 3 B |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 17.3 B | 3 B | 9.83 B |
Total Liabilities of other stocks in the Medical devices industry
| Issuer | Total Liabilities | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Bio-Rad Laboratories
BIO
|
2.79 B | $ 293.17 | -0.94 % | $ 8.27 B |  USA |
 |
Bruker Corporation
BRKR
|
3.99 B | $ 39.05 | -1.09 % | $ 5.82 K | USA |
 |
Align Technology
ALGN
|
2.36 B | $ 187.58 | 0.56 % | $ 14 B | USA |
 |
Axonics Modulation Technologies
AXNX
|
89.2 M | - | - | $ 3.31 B | USA |
 |
Aziyo Biologics
AZYO
|
34.7 M | - | 1.37 % | $ 20.5 M | USA |
 |
BioSig Technologies
BSGM
|
54.2 M | - | 37.08 % | $ 85.7 M | USA |
 |
GenMark Diagnostics, Inc.
GNMK
|
129 M | - | - | $ 1.77 B | USA |
 |
Acutus Medical
AFIB
|
54.8 M | - | -26.83 % | $ 2.62 M | USA |
 |
Conformis
CFMS
|
39.9 M | - | - | $ 16.4 M | USA |
 |
Avinger
AVGR
|
20 M | - | -20.74 % | $ 369 K | USA |
 |
AdaptHealth Corp.
AHCO
|
2.79 B | $ 12.34 | -2.49 % | $ 1.67 B | USA |
 |
Allied Healthcare Products
AHPI
|
3.56 M | - | 3.58 % | $ 2.21 M | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
5.95 M | - | -5.86 % | $ 30.6 M | USA |
 |
Cytosorbents Corporation
CTSO
|
38.3 M | $ 0.62 | 4.87 % | $ 38.6 M | USA |
 |
EDAP TMS S.A.
EDAP
|
45.2 M | $ 3.62 | 2.84 % | $ 136 M |  France |
 |
LENSAR
LNSR
|
83.7 M | $ 5.94 | -4.96 % | $ 71 M | USA |
 |
Boston Scientific Corporation
BSX
|
16.7 B | $ 64.43 | -0.29 % | $ 95.4 B | USA |
 |
Apollo Endosurgery
APEN
|
77.6 M | - | - | $ 475 M | USA |
 |
Cardiovascular Systems
CSII
|
73.2 M | - | 0.15 % | $ 844 M | USA |
 |
Eargo
EAR
|
31.2 M | - | - | $ 10.2 M | USA |
 |
ClearPoint Neuro
CLPT
|
69.7 M | $ 10.62 | 1.53 % | $ 301 M | USA |
 |
Dynatronics Corporation
DYNT
|
12.2 M | - | 14.99 % | $ 929 K | USA |
 |
Electromed
ELMD
|
10.6 M | $ 25.45 | -1.03 % | $ 215 M | USA |
 |
Second Sight Medical Products
EYES
|
23.7 M | - | -0.97 % | $ 54.4 M | USA |
 |
CryoLife, Inc.
CRY
|
461 M | - | -4.14 % | $ 702 M | USA |
 |
Sintx Technologies
SINT
|
6.58 M | $ 2.77 | 1.09 % | $ 7.68 M | USA |
 |
Soliton, Inc.
SOLY
|
2.82 M | - | -1.42 % | $ 435 M | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
3.44 K | - | -1.98 % | $ 98.3 M | USA |
 |
GBS
GBS
|
5.44 M | - | -0.57 % | $ 7.12 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
21.1 M | - | 0.03 % | $ 1.58 B |  Israel |
 |
Misonix, Inc.
MSON
|
57.2 M | - | - | $ 462 M | USA |
 |
Neovasc
NVCN
|
14 M | - | - | $ 111 M |  Canada |
 |
Stryker Corporation
SYK
|
25.4 B | $ 340.26 | -0.29 % | $ 130 B | USA |
 |
OrthoPediatrics Corp.
KIDS
|
162 M | $ 17.36 | -2.75 % | $ 407 M | USA |
 |
Globus Medical
GMED
|
730 M | $ 93.58 | -1.03 % | $ 12.7 B | USA |
 |
Tactile Systems Technology
TCMD
|
55 M | $ 25.41 | 0.24 % | $ 581 M | USA |
 |
TELA Bio
TELA
|
75.1 M | $ 0.69 | 5.6 % | $ 32.4 M | USA |
 |
Helius Medical Technologies
HSDT
|
5.34 M | $ 1.99 | 2.58 % | $ 1.21 M | USA |
 |
Butterfly Network
BFLY
|
87.2 M | $ 5.26 | 8.23 % | $ 1.11 B | USA |
 |
Intersect ENT, Inc.
XENT
|
160 M | - | - | $ 955 M | USA |
 |
Inogen
INGN
|
106 M | $ 6.2 | -0.08 % | $ 165 M | USA |
 |
TransMedics Group
TMDX
|
595 M | $ 112.47 | -3.13 % | $ 3.82 B | USA |
 |
IRIDEX Corporation
IRIX
|
24.2 M | $ 1.03 | -0.96 % | $ 17.4 M | USA |
 |
Tandem Diabetes Care
TNDM
|
726 M | $ 20.6 | -0.29 % | $ 1.4 B | USA |
 |
BIOLASE
BIOL
|
33.1 M | - | -13.19 % | $ 166 K | USA |
 |
Delcath Systems
DCTH
|
12.4 M | $ 10.91 | -0.73 % | $ 391 M | USA |
 |
Inspire Medical Systems
INSP
|
126 M | $ 57.91 | 2.24 % | $ 1.7 B | USA |
 |
CONMED Corporation
CNMD
|
1.29 B | $ 38.57 | -2.21 % | $ 1.2 B | USA |